These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18162942)

  • 1. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections.
    Fergie J; Purcell K
    Pediatr Infect Dis J; 2008 Jan; 27(1):67-8. PubMed ID: 18162942
    [No Abstract]   [Full Text] [Related]  

  • 2. Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Creech CB; Beekmann SE; Chen Y; Polgreen PM
    Pediatr Infect Dis J; 2008 Mar; 27(3):270-2. PubMed ID: 18277924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic options for treating community-acquired MRSA.
    Powell JP; Wenzel RP
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Hyun DY; Mason EO; Forbes A; Kaplan SL
    Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) paediatric clone among skin and soft-tissue infections in Buenos Aires.
    Tokumoto MB; Ybarra V; Torreno M; Rodríguez M; Ramírez MS; Jordá Vargas L; Centrón D
    Int J Antimicrob Agents; 2007 Nov; 30(5):469-71. PubMed ID: 17683914
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF; Frank AL
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):91-100. PubMed ID: 16441212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Gorwitz RJ
    Pediatr Infect Dis J; 2008 Jan; 27(1):1-7. PubMed ID: 18162929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Whitman TJ
    Dis Mon; 2008 Dec; 54(12):780-6. PubMed ID: 18996280
    [No Abstract]   [Full Text] [Related]  

  • 10. Methicillin-resistant Staphylococcus aureus and athletes.
    Kirkland EB; Adams BB
    J Am Acad Dermatol; 2008 Sep; 59(3):494-502. PubMed ID: 18550208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization.
    Terushkin V; Brownell I
    J Drugs Dermatol; 2008 Jun; 7(6):597-601. PubMed ID: 18561595
    [No Abstract]   [Full Text] [Related]  

  • 12. Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    da Silva LV; Zavascki AP; de Souza MV; Marcadenti A
    Am J Surg; 2008 Oct; 196(4):618-9. PubMed ID: 18809069
    [No Abstract]   [Full Text] [Related]  

  • 13. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003.
    Can Commun Dis Rep; 2003 Jun; 29(12):110-2. PubMed ID: 12822295
    [No Abstract]   [Full Text] [Related]  

  • 14. Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Widmer AF
    Clin Infect Dis; 2008 Mar; 46(5):656-8. PubMed ID: 18225983
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ; Egan DJ; Pelletier AJ; Espinola JA; Hooper DC; Camargo CA
    Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge.
    Karchmer AW; Bayer AS
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S342-3. PubMed ID: 18462088
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections.
    Cohen PR; Grossman ME
    J Am Acad Dermatol; 2004 Jul; 51(1):132-5. PubMed ID: 15243539
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010.
    De Angelis G; Cipriani M; Cauda R; Tacconelli E
    Clin Infect Dis; 2011 Jun; 52(12):1471-2; author reply 1472. PubMed ID: 21628490
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Daum RS
    N Engl J Med; 2007 Jul; 357(4):380-90. PubMed ID: 17652653
    [No Abstract]   [Full Text] [Related]  

  • 20. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Feb; 52(5):88. PubMed ID: 12588006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.